Scott D. Rowley

12.8k citations

168 papers · 8.0k indexed · 2 hit papers · h-index 44

Impact in

Hematology top 0.05%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
Genetics top 0.5%
- Mesenchymal stem cell research

Papers in

Hematology 116
- Hematopoietic Stem Cell Transplantation 87
- Acute Myeloid Leukemia Research 25
- Multiple Myeloma Research and Treatments 25
- Chronic Myeloid Leukemia Treatments 15
Genetics 34
- Mesenchymal stem cell research 19

Co-authors: Rainer Storb Jack W. Singer K Lilleby William Bensinger CD Buckner Taner Demirer Ted Gooley Frederick R. Appelbaum
Journals: Blood (62 papers)Biology of Blood and Marrow Transplantation (23 papers)Journal of Clinical Oncology (9 papers)Bone Marrow Transplantation (9 papers)Transfusion (4 papers)
Partner nations: United States Canada Iceland

In The Last Decade

Scott D. Rowley

159 papers receiving 7.8k citations

Hit Papers

align trajectories log scale

Transplantation of Bone Marrow as Compared with Peripheral-Blood Cells from HLA-Identical Relatives in Patients with Hematologic Cancers 2001 · 700 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2001 New England Journal of Medicine
1995 Journal of Clinical Oncology

Peers

Countries citing papers authored by Scott D. Rowley

Since Specialization

Citations

This map shows the geographic impact of Scott D. Rowley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott D. Rowley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott D. Rowley more than expected).

Fields of papers citing papers by Scott D. Rowley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott D. Rowley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott D. Rowley. The network helps show where Scott D. Rowley may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Scott D. Rowley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Scott D. Rowley Line = papers co-authored together Scott D. Rowley links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Peripheral Blood Tumor Associated Cell-Free DNA Testing as a Predictor for Relapse Postallogeneic Stem Cell Transplant for Acute Myelogenous Leukemia Transplantation and Cellular Therapy ·J. Leo Cefkin, Maciej Kabat, Andrew Ip, Beatriz Albi-Martínez, Hyung C. Suh, Christina Cho, David H. Vesole, Michèle L. Donato, Maher Albitar, Scott D. Rowley	2025	0
2	cfDNA Chimerism and Somatic Mutation Testing in Early Prediction of Relapse After Allogeneic Stem Cell Transplantation for Myeloid Malignancies Cancers ·Scott D. Rowley, Maher Albitar, G Visintini, Alaa M. Ali, D. X. Li, Hyung C. Suh, André Goy, Michèle L. Donato	2025	1
3	Patient-centered communication’s association with trust, satisfaction, and perception of electronic health records use among newly diagnosed patients with cancer Frontiers in Communication ·Safa Elkefi, Onur Asan, Zhongyuan Yu, Tina Yen, Scott D. Rowley	2024	3
4	Using Targeted Transcriptome and Machine Learning of Pre- and Post-Transplant Bone Marrow Samples to Predict Acute Graft-versus-Host Disease and Overall Survival after Allogeneic Stem Cell Transplantation Cancers ·Scott D. Rowley, Smoke Elser, Perihan TUNC, Hoàng Việt Dũng, Albert Lee, Shinichi Munesue, 林丰, G Liard, Hong Zhang, Ho-nam Fong, Hyung C. Suh, Michèle L. Donato, Maher Albitar, Andrew Ip	2024	5
5	Prevalence of Non-Hodgkin Lymphoma Patients at High Risk of Failure after CAR T-Cell Therapy Eligible for Bridging Radiation Therapy International Journal of Radiation OncologyBiologyPhysics ·K. Saravanakumar, T Pescio, 和雄澤中, Karine A. Al Feghali, Lydia Pascual, Michael Marafelias, Xia Sheng, André Goy, Tatyana Feldman, Yaojun Zhang, Scott D. Rowley, Andrew Ip	2023	0
6	Greater Social Isolation and Social Constraints Prior to Hematopoietic Stem Cell Transplant Are Associated with Greater Anxiety and Depressive Symptoms International Journal of Behavioral Medicine ·良美東, Sanju Singh, Wang Ying Lai, Hans-Jürgen Keding, E DAPOSCRUZ, Annette L. Stanton, Heiðdís Valdimarsdóttir, Betina R. Yanez, Pashna N. Munshi, Scott D. Rowley, Christine Rini, Kristi D. Graves	2023	2
7	Placental expanded mesenchymal-like cells (PLX-R18) for poor graft function after hematopoietic cell transplantation: A phase I study Bone Marrow Transplantation ·Joseph P. McGuirk, Leland Metheny, Luis Piñeiro, Mark R. Litzow, Scott D. Rowley, Batia Avni, Roni Tamari, Hillard M. Lazarus, Jacob M. Rowe, Ni Wayan Ega Multiyani, 広大田中, Y Dinguirard, Tsila Zuckerman	2023	2
8	Sustained Hematopoietic Engraftment Potential after Prolonged Storage of Cryopreserved Hematopoietic Stem Cells Used in Salvage Autologous Stem Cell Transplantation Transplantation and Cellular Therapy ·Pindak Ron, Ivar Isma Gymnastiar, Ronit Reich‐Slotky, Pashna N. Munshi, Noa Biran, Michèle L. Donato, David S. Siegel, David H. Vesole, Ibolya Korsós, Scott D. Rowley	2022	1
9	Efficacy of expressive helping in adult hematologic cancer patients undergoing stem cell transplant: protocol for the Writing for Insight, Strength, and Ease (WISE) study’s two-arm randomized controlled trial Trials ·L Foroghi Biland, 黒田定雄, E DAPOSCRUZ, M Alavaikko, Jane E. Austin, George Luta, Lucas Correia Sampaio, Scott D. Rowley, Themba Nyirenda, Marquita W. Lewis‐Thames, Annette L. Stanton, Heiðdís Valdimarsdóttir, Kristi D. Graves, Christine Rini	2021	3
10	Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study UNC Libraries ·Brandon Hayes‐Lattin, P. Amarendra, Michael Linenberger, Galen E. Switzer, Mark R. Litzow, Dennis L. Confer, М.Б. Буравлев, Brian J. Bolwell, Marcie Riches, Rebecca Drexler, Mary M. Horowitz, Roberta King, Bronwen E. Shaw, Nagaraju Nekkala, Chris Korth, Michael A. Pulsipher, Scott D. Rowley	2020	1
11	Midostaurin after allogeneic stem cell transplant in patients with FLT3-internal tandem duplication-positive acute myeloid leukemia Bone Marrow Transplantation ·Richard T. Maziarz, Mark J. Levis, Mrinal M. Patnaik, Bart L. Scott, Sanjay Mohan, Abhinav Deol, Scott D. Rowley, Dennis Dong Hwan Kim, Daniela Hernandez, Trivikram Rajkhowa, Natalia Velázquez, Gaetano Bonifacio, Ming-yu Han, Das Purkayastha, Hugo F. Fernández	2020	100
12	Effects of Social Support Source and Effectiveness on Stress Buffering After Stem Cell Transplant International Journal of Behavioral Medicine ·Marjorie Margolis, Jane E. Austin, Lisa M. Wu, Heiðdís Valdimarsdóttir, Annette L. Stanton, Scott D. Rowley, 和子森田, Christine Rini	2019	9
13	Radius: A Phase 2 Randomized Trial Investigating Standard of Care ± Midostaurin after Allogeneic Stem Cell Transplant in FLT3-ITD-Mutated AML Blood ·Richard T. Maziarz, Mrinal M. Patnaik, Bart L. Scott, Sanjay Mohan, Abhinav Deol, Scott D. Rowley, Dennis Kim, Natalia Velázquez, Gaetano Bonifacio, Ming-yu Han, Das Purkayastha, Hugo F. Fernández	2018	51
14	Platelet Transfusion for Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Journal of Clinical Oncology ·Charles A. Schiffer, Kari Bohlke, Meghan Delaney, Heather Hume, Sadat Ahmed Abdela, Jeffrey McCullough, James Omel, John M. Rainey, Paolo Rebulla, Scott D. Rowley, M. Troner, Kenneth C. Anderson	2017	211
15	Comparative Outcomes after Haploidentical or Unrelated Donor Bone Marrow or Blood Stem Cell Transplantation in Adult Patients with Hematological Malignancies Biology of Blood and Marrow Transplantation ·G Visintini, Hongkun Wang, Scott D. Rowley, Ling Cai, Andrew L. Pecora, Alan P Skarbnik, David H. Vesole, Barbara Adler‐Brecher, Daniel Kim, Michèle L. Donato	2016	38
16	Health-Related Quality of Life among Older Related Hematopoietic Stem Cell Donors (>60 Years) Is Equivalent to That of Younger Related Donors (18 to 60 Years): A Related Donor Safety Study Biology of Blood and Marrow Transplantation ·Galen E. Switzer, Nagaraju Nekkala, P. Amarendra, М.Б. Буравлев, Rebecca Drexler, Daniel Bernardino, Dennis L. Confer, Mary M. Horowitz, Roberta King, Bronwen E. Shaw, Marcie Riches, Brandon Hayes‐Lattin, Michael Linenberger, Brian J. Bolwell, Scott D. Rowley, Mark R. Litzow, Michael A. Pulsipher	2016	8
17	Multicenter study of banked third-party virus-specific T cells to treat severe viral infections after hematopoietic stem cell transplantation Blood ·Ann M. Leen, Catherine M. Bollard, Adam Mendizabal, Elizabeth J. Shpall, Paul Szabolcs, Joseph H. Antin, Neena Kapoor, Sung‐Yun Pai, Scott D. Rowley, Partow Kebriaei, Bimalangshu R. Dey, Bambi Grilley, Adrian P. Gee, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop	2013	392
18	Donor CD3 Chimerism After Allogeneic Transplantation Predicts Probability Of Relapse For Patients Treated For Acute Myelogenous Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Non-Hodkgin's Lymphoma (NHL) Blood ·Emma Krögh, Michèle L. Donato, Themba Nyirenda, David H. Vesole, Andrew L. Pecora, Stuart L. Goldberg, André Goy, Tatyana Feldman, Anthony R. Mato, Pritish K. Bhattacharyya, G Visintini, B. Planquette, H.O. Beisland, Scott D. Rowley	2013	1
19	Evaluation of Oral Beclomethasone Dipropionate for Prevention of Acute Graft-versus-Host Disease Biology of Blood and Marrow Transplantation ·Paul J. Martin, Terry Furlong, Scott D. Rowley, Steven A. Pergam, Michele Lloid, Mark M. Schubert, Kevin Horgan, Barry E. Storer	2011	16
20	A randomized, placebo-controlled trial of oral beclomethasone dipropionate as a prednisone-sparing therapy for gastrointestinal graft-versus-host disease Blood ·David M. Hockenbery, Scott Cruickshank, Timothy C. Rodell, Ted Gooley, Friedrich Schuening, Scott D. Rowley, Donald S. David, M Cesareo, A. Lees, Sunil Abhyankar, M Bouvier, George B. McDonald, (unknown)	2007	79

About Scott D. Rowley

Scott D. Rowley is a scholar working on Hematology, Genetics, Transplantation, Oncology and Pediatrics, Perinatology and Child Health, having authored 168 papers that have together received 8.0k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (87 papers), Acute Myeloid Leukemia Research (25 papers), Multiple Myeloma Research and Treatments (25 papers), Mesenchymal stem cell research (19 papers), Childhood Cancer Survivors' Quality of Life (16 papers), Chronic Myeloid Leukemia Treatments (15 papers), Cancer survivorship and care (12 papers) and Neutropenia and Cancer Infections (11 papers). The work is most often cited by research in Hematology (5.2k citations), Genetics (1.6k citations), Transplantation (280 citations), Oncology (2.6k citations) and Immunology (1.7k citations). Scott D. Rowley has collaborated with scholars based in United States, Canada and Iceland. Frequent co-authors include Rainer Storb, Jack W. Singer, K Lilleby, William Bensinger, CD Buckner, Taner Demirer, Ted Gooley, Frederick R. Appelbaum, Thomas R. Chauncey and Paul J. Martin. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Bone Marrow Transplantation and Transfusion.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact